Drug-resistant tuberculosis medical therapy

Jump to navigation Jump to search

Tuberculosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tuberculosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Children

HIV Coinfection

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Special Conditions
Drug-resistant

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Drug-resistant tuberculosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Drug-resistant tuberculosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Drug-resistant tuberculosis medical therapy

CDC on Drug-resistant tuberculosis medical therapy

Drug-resistant tuberculosis medical therapy in the news

Blogs on Drug-resistant tuberculosis medical therapy

Directions to Hospitals Treating Tuberculosis

Risk calculators and risk factors for Drug-resistant tuberculosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Overview

Multiple Drug-Resistant (MDR) Tuberculosis

MDR-TB is defined as resistance to isoniazid and rifampicin, with or without resistance to other first-line drugs.

MDR Tuberculosis

  ▸  Adults

  ▸  Children

Non-Purulent Cellulitis - Adults
Preferred Regimen
▸ '
Non-Purulent Cellulitis - Children
Preferred Regimen

Extensively Drug-Resistant XDR Tuberculosis

XDR-TB is defined as resistance to at least isoniazid and rifampicin, and to any fluoroquinolone, and to any of the three second-line injectables (amikacin, capreomycin, and kanamycin).

XDR Tuberculosis

  ▸  Adults

  ▸  Children

Non-Purulent Cellulitis - Adults
Preferred Regimen
▸ '
Non-Purulent Cellulitis - Children
Preferred Regimen

Extremely Drug-Resistant (XXDR) Tuberculosis

References